185 related articles for article (PubMed ID: 36499320)
1. Irrespective of Plaque Activity, Multiple Sclerosis Brain Periplaques Exhibit Alterations of Myelin Genes and a TGF-Beta Signature.
Nataf S; Guillen M; Pays L
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499320
[TBL] [Abstract][Full Text] [Related]
2. A Unique TGFB1-Driven Genomic Program Links Astrocytosis, Low-Grade Inflammation and Partial Demyelination in Spinal Cord Periplaques from Progressive Multiple Sclerosis Patients.
Nataf S; Barritault M; Pays L
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28981455
[TBL] [Abstract][Full Text] [Related]
3. N-myc downstream regulated family member 1 (NDRG1) is enriched in myelinating oligodendrocytes and impacts myelin degradation in response to demyelination.
Marechal D; Dansu DK; Castro K; Patzig J; Magri L; Inbar B; Gacias M; Moyon S; Casaccia P
Glia; 2022 Feb; 70(2):321-336. PubMed ID: 34687571
[TBL] [Abstract][Full Text] [Related]
4. TGFB1-Mediated Gliosis in Multiple Sclerosis Spinal Cords Is Favored by the Regionalized Expression of HOXA5 and the Age-Dependent Decline in Androgen Receptor Ligands.
Nataf S; Guillen M; Pays L
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779094
[TBL] [Abstract][Full Text] [Related]
5. Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
Lieury A; Chanal M; Androdias G; Reynolds R; Cavagna S; Giraudon P; Confavreux C; Nataf S
Glia; 2014 Oct; 62(10):1645-58. PubMed ID: 24910450
[TBL] [Abstract][Full Text] [Related]
6. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis.
Möller JR; Yanagisawa K; Brady RO; Tourtellotte WW; Quarles RH
Ann Neurol; 1987 Oct; 22(4):469-74. PubMed ID: 2449119
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of the myelin-associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients.
Johnson D; Sato S; Quarles RH; Inuzuka T; Brady RO; Tourtellotte WW
J Neurochem; 1986 Apr; 46(4):1086-93. PubMed ID: 2419505
[TBL] [Abstract][Full Text] [Related]
9. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
[TBL] [Abstract][Full Text] [Related]
10. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
12. Demyelination versus remyelination in progressive multiple sclerosis.
Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
[TBL] [Abstract][Full Text] [Related]
15. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
Rahmanzadeh R; Lu PJ; Barakovic M; Weigel M; Maggi P; Nguyen TD; Schiavi S; Daducci A; La Rosa F; Schaedelin S; Absinta M; Reich DS; Sati P; Wang Y; Bach Cuadra M; Radue EW; Kuhle J; Kappos L; Granziera C
Brain; 2021 Jul; 144(6):1684-1696. PubMed ID: 33693571
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
[TBL] [Abstract][Full Text] [Related]
17. The Fulcrum of Demyelination in Multiple Sclerosis.
Ganesan A; Muralidharan P; Ramya LN
Curr Protein Pept Sci; 2023; 24(7):579-588. PubMed ID: 37461348
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line.
Huang CJ; Nazarian R; Lee J; Zhao PM; Espinosa-Jeffrey A; de Vellis J
Int J Dev Neurosci; 2002; 20(3-5):289-96. PubMed ID: 12175864
[TBL] [Abstract][Full Text] [Related]
19. Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy.
Ladopoulos T; Matusche B; Bellenberg B; Heuser F; Gold R; Lukas C; Schneider R
Neuroimage Clin; 2022; 36():103166. PubMed ID: 36081258
[TBL] [Abstract][Full Text] [Related]
20. Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis.
Rodriguez M; Prayoonwiwat N; Howe C; Sanborn K
J Neuropathol Exp Neurol; 1994 Mar; 53(2):136-43. PubMed ID: 7509847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
